Julia Edin, a Crohn’s patient from Norway tells us about her experience using IBDoc® at home.
Julia Edin, a Crohn’s patient from Norway tells us about her
Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
The Workflow Revolution Continues for Serum Calprotectin June 29, 2023
New Presentation Format for UK NEQAS April 8, 2022
Point-of-Care Calprotectin Testing Just Got Easier with New and Improved Quantum Blue® III March 17, 2021
New App Helps Bowel Disease Patients Monitor Their Own Treatment February 24, 2021
Don't underestimate the power of screening. There is a greater than 90 percent cure if bowel cancer is diagnosed early.
The NHS bowel cancer screening service is easy, painless and takes little time to complete. You must be registered with a GP. (🧵1/6)
#OneThing we’re passionate about is early diagnosis. The earlier #BowelCancer is spotted, the more treatable it’s likely to be.
We're encouraging everyone this #BowelCancerAwarenessMonth to be aware of the possible symptoms of the disease. Learn more: https://bit.ly/3TVlxfp